Skip to main content
. 2013 Oct 29;109(12):3005–3013. doi: 10.1038/bjc.2013.679

Table 4. Pelvic floor muscle strength in prostate cancer patients treated with radiotherapy in RePCa: a randomised controlled rehabilitation study.

Pelvic floor muscle strength
Intervention group, n=79
Control group, n=82
 
Mean (95%CI) Study population pre-radiation Pre-intervention Post intervention Pre-intervention Post intervention P-valuea
No. of participants
n=156
n=73
n=68
n=75
n=71
 
Digital evaluationb
4.0 (3.8;4.1)
3.8 (3.5;4.0)
3.9 (3.6;4.1)
3.8 (3.6;4.1)
3.7 (3.5;4.0)
NS
Static strength no. of seconds to hold one contraction
34.4 (31.1;37.7)
35.2 (30.2;40.2)
36.1 (31.0;41.2)
31.6 (26.6;36.6)
32.9 (28.0;37.8)
NS
Dynamic strength no. of contractions during 60 s
22.2 (19.9;24.5)
21.2 (17.7;24.7)
22.7 (18.9;26.5)
19.1 (15.9;22.3)
19.2 (15.9;22.6)
NS
No. of participants
n=156
n=72
n=66
n=71
n=71
 
EMG average activity (μV)
38.2 (34.8;41.6)
31.3 (27.9;34.8)
24.7 (21.7;27.7)
31.6 (27.3;35.9)
23.3 (20.4;26.2)
NS
EMG average rest (μV) 6.8 (6.2;7.5) 5.8 (5.0;6.6) 4.8 (4.0;5.5) 5.5 (4.9;6.1) 4.9 (3.6;6.2) NS

Abbreviations: CI=class interval; EMG=electromyography.

a

Post-intervention differences between groups. Wilcoxon Sign-rank test. Reported P-values are two-sided and P<0.05 was considered statistically significant.

b

Measured by Modified Oxford Scale 0–6.